Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12614000054617
Ethics application status
Approved
Date submitted
7/01/2014
Date registered
20/01/2014
Date last updated
20/01/2014
Type of registration
Retrospectively registered
Titles & IDs
Public title
A study of providing adult smokers, who smoke at least one cigarette per day, the opportunity to sample a range of nicotine replacement therapies (NRTs) in everyday non-medical community locations, to determine if this is acceptable to smokers, and whether it increases their motivation to quit smoking, encourages them to use NRTs, and helps them to quit smoking and remain abstinent for three months.
Query!
Scientific title
A pilot uncontrolled single arm non-randomised open-label trial of the acceptability and effect on motivation to quit and compliance with use of nicotine replacement therapy of supplying nicotine replacement therapies to smokers in community locations regardless of their motivation to quit smoking.
Query!
Secondary ID [1]
283866
0
Nil
Query!
Universal Trial Number (UTN)
U1111-1145-4390
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Tobacco dependence
290848
0
Query!
Smoking addiction
290849
0
Query!
Condition category
Condition code
Mental Health
291212
291212
0
0
Query!
Addiction
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The trial will consist of kiosks in community locations where smokers go about their everday lives (such as shopping malls), which are staffed by trained quit coaches. People who smoke at least once per day, will be given the opportunity to sample a range of nicotine replacement therapies while being guided in the appropriate manner of using them by an expert coach. They can choose from the following products: Nicotine patch (21mg, 14mg, 7mg); nicotine gum (2mg, 4mg); nicotine lozenge (2mg, 1mg); nicotine mouthspray (QuickMist) 1mg/spray; Nicorette Inhalator 15mg. They can choose to sample as many products as they wish, however, if participants have not voluntarily chosen to try wearing a patch, they will be gently encouraged to do so, although they can decline to try wearing a patch if they do not want to. If participatns wish, they may take a free sample of a week's worth of as many of the products as they want (however, they must be products that they have chosen to sample at the kiosk under supervision of an expert coach).
Query!
Intervention code [1]
288543
0
Treatment: Drugs
Query!
Comparator / control treatment
There is no comparator or control treatment as this is a single-arm trial.
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
291202
0
7-day point prevalence (not smoking even a puff in the past 7 days). This will be by self-report (either by telephone or by visitng the kiosk at the mall), and if the subjects are willing to visit the kiosk at the mall, this will be verified by an exhaled carbon monoxide level of less than 10 parts per million.
Query!
Assessment method [1]
291202
0
Query!
Timepoint [1]
291202
0
Weeks 1, 2, 4, 8, and 18 after first attendance at the kiosk. At these time-points every effort will be make to encourage participants to attend the kiosk to provide carbon monoxide verification of their abstinence status (abstinence defined as <10ppm), however if subjects are unwilling to visit the mall, this outcome will be measured by self-report over the telephone.
Query!
Primary outcome [2]
291203
0
Amount of nicotine replacement therapy/therapies used, measured by self-report via telephone or at visit to the kiosk locations.
Query!
Assessment method [2]
291203
0
Query!
Timepoint [2]
291203
0
Weeks 1, 2, 4, 8, and 18 after attending the kiosk.
Query!
Secondary outcome [1]
306226
0
Acceptability of nicotine replacement therapies, rated on ad hoc Likert scales
Query!
Assessment method [1]
306226
0
Query!
Timepoint [1]
306226
0
weeks 1, 2, 4, 8, and 18 after first visit to the kiosk
Query!
Secondary outcome [2]
306227
0
Duration of abstinence (record the number of days of not smoking since previous follow-up)
Query!
Assessment method [2]
306227
0
Query!
Timepoint [2]
306227
0
weeks 1, 2, 4, 8, and 18 after first visit to the kiosk
Query!
Eligibility
Key inclusion criteria
18 years or older, and report smoking daily
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Non-daily smokers
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Subjects will be enrolled if they meet the inclusion criteria, and will be allocated to treatment according to what products they would like to use (this is a non-controlled study).
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Non-controlled study, and subjects choose which therapies they would like to use.
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
Logist regression and generalised linear models will be used to determine what factors influenced abstinence and the amount of nicotine replacement therapies that were used.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
14/01/2014
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
1000
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
5725
0
New Zealand
Query!
State/province [1]
5725
0
Lower North Island
Query!
Funding & Sponsors
Funding source category [1]
288512
0
Government body
Query!
Name [1]
288512
0
Ministry of Health
Query!
Address [1]
288512
0
Tobacco Control Programme
Community Health Service Improvement
Sector Capability and Implementation
Ministry of Health
133 Molesworth Street
Thorndon
Wellington 6011
Query!
Country [1]
288512
0
New Zealand
Query!
Primary sponsor type
Government body
Query!
Name
Ministry of Health
Query!
Address
Tobacco Control Programme
Community Health Service Improvement
Sector Capability and Implementation
Ministry of Health
133 Molesworth Street
Thorndon
Wellington 6011
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
287218
0
None
Query!
Name [1]
287218
0
Query!
Address [1]
287218
0
Query!
Country [1]
287218
0
Query!
Other collaborator category [1]
277751
0
University
Query!
Name [1]
277751
0
University of Otago, Wellington
Query!
Address [1]
277751
0
23a Mein Street
Newtown
Wellington 6041
Query!
Country [1]
277751
0
New Zealand
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
290375
0
Central Health and Disability Ethics Committee
Query!
Ethics committee address [1]
290375
0
Health and Disability Ethics Committees 1 The Terrace PO Box 5013 Wellington 6011
Query!
Ethics committee country [1]
290375
0
New Zealand
Query!
Date submitted for ethics approval [1]
290375
0
Query!
Approval date [1]
290375
0
31/07/2013
Query!
Ethics approval number [1]
290375
0
13/CEN/108
Query!
Summary
Brief summary
This is a pilot study of making a range of nicotine replacement therapies available to smokers in locations where they go about their everyday lives, regardless of their level of motivation to quit smoking. The hypothesis is that giving smokers the opportunity to sample a range of therapies, under the guidance of an expert coach, will increase their motivation to quit, increase their usage of nicotine replacement therapy, and lead them to try to quit smoking.
Query!
Trial website
www.otago.ac.nz/enjoy
Query!
Trial related presentations / publications
None so far.
Query!
Public notes
None.
Query!
Contacts
Principal investigator
Name
45378
0
Dr Brent Caldwell
Query!
Address
45378
0
University of Otago, Wellington
Department of Medicine
23a Mein Street
Newtown
Wellington 6041
Query!
Country
45378
0
New Zealand
Query!
Phone
45378
0
+64 (0)4 9186041
Query!
Fax
45378
0
Query!
Email
45378
0
[email protected]
Query!
Contact person for public queries
Name
45379
0
Brent Caldwell
Query!
Address
45379
0
University of Otago, Wellington
Department of Medicine
23a Mein Street
Newtown
Wellington 6041
Query!
Country
45379
0
New Zealand
Query!
Phone
45379
0
+64 (0)4 9186041
Query!
Fax
45379
0
Query!
Email
45379
0
[email protected]
Query!
Contact person for scientific queries
Name
45380
0
Brent Caldwell
Query!
Address
45380
0
University of Otago, Wellington
Department of Medicine
23a Mein Street
Newtown
Wellington 6041
Query!
Country
45380
0
New Zealand
Query!
Phone
45380
0
+64 (0)4 9186041
Query!
Fax
45380
0
Query!
Email
45380
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF